Chest
-
Asthma PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To assess the knowledge about asthma from employees of a public school in a large urban center in Brazil ⋯ The following authors have nothing to disclose: Ana Carla Coelho, Carolina Souza-Machado, Thiara Silva de Oliveira, Tássia Nascimento, Jane Cabral, Adelmir Souza-MachadoNo Product/Research Disclosure Information.
-
COPD Rehabilitation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Cystic fibrosis (CF) is a multisystemic disease characterized by a limited exercise capacity. Exercise training (ET) using systems that improve the adherence to pulmonary rehabilitation programs is a key factor to guarantee the benefits of this therapy. Our goal was to evaluate the efficacy of a long term domiciliary exercise program using the WiiTM video game platform as a training system in patients with CF. ⋯ The following authors have nothing to disclose: Tamara Del Corral Nuñez-Flores, Roberto Martinez Alejos, Angels Cebria i Iranzo, Jordi Vilaró, Roberto RabinovichNo Product/Research Disclosure Information.
-
ILD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: No published data is available to provide any information about the status of Interstitial Lung Diseases (ILD) in Pakistan. However this study is in continuation of presented data from 2008-11 (Ansarie et al, ERS 2012) to determine the ongoing incidence and relative frequency of various ILDs in Karachi, it's most populous multiethnic city (20 million). ⋯ The following authors have nothing to disclose: Mosavir Ansarie, Asif Naseem, Aneeka Kasmani, Rasheed Ahmed, Muhammad AzeemuddinNo Product/Research Disclosure Information.
-
COPD Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: Indacaterol (IND) is a once daily long acting beta 2 agonist (LABA). This study evaluated how IND can be introduced into real life treatment regimens for COPD in Israel. ⋯ Gabriel Izbicki: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium David Shitrit: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium Meir Raz: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium Zeev Vilayi-Weiler: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium Gershon Fink: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium Yehuda Schwarz: Consultant fee, speaker bureau, advisory committee, etc.: Advisor Honorarium Sari Lubin: Employee: Salary Lital Daniel: Employee: Salary Tamar Rachmilewitz: Employee: Salary Mordechai Kramer: Consultant fee, speaker bureau, advisory committee, etc.: Advisor HonorariumNo Product/Research Disclosure Information.
-
Pleural Disease/Pleural Effusion PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To assess the discriminatory power of pleural ADA levels in pleural effusions lymphomas. - Define the cutoff level in these cases. ⋯ The following authors have nothing to disclose: Deisy Barrios Barreto, Esteban Perez Rodriguez, Carolina Gotera, Patricia Lazo Meneses, Paola Arrieta Narvaez, Rosa Mirambeaux Villalona, Salvador Diaz Lobato, Sagrario Mayoralas AlisesNo Product/Research Disclosure Information.